Cargando…
CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors
Malignant peripheral nerve sheath tumors (MPNSTs) are highly aggressive soft tissue sarcomas with limited treatment options, and new effective therapeutic strategies are desperately needed. We observe antiproliferative potency of genetic depletion of PTPN11 or pharmacological inhibition using the SH...
Autores principales: | Wang, Jiawan, Calizo, Ana, Zhang, Lindy, Pino, James C., Lyu, Yang, Pollard, Kai, Zhang, Xiaochun, Larsson, Alex T., Conniff, Eric, Llosa, Nicolas J., Wood, David K., Largaespada, David A., Moody, Susan E., Gosline, Sara J., Hirbe, Angela C., Pratilas, Christine A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672174/ https://www.ncbi.nlm.nih.gov/pubmed/38000020 http://dx.doi.org/10.1126/sciadv.adg8876 |
Ejemplares similares
-
CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon restoration of RB function in malignant peripheral nerve sheath tumors
por: Wang, Jiawan, et al.
Publicado: (2023) -
Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology
por: Larsson, Alex T, et al.
Publicado: (2023) -
RB1 loss triggers dependence on ESRRG in retinoblastoma
por: Field, Matthew G., et al.
Publicado: (2022) -
Mad3 modulates the G(1) Cdk and acts as a timer in the Start network
por: Pérez, Alexis P., et al.
Publicado: (2022) -
RB1 loss overrides PARP inhibitor sensitivity driven by RNASEH2B loss in prostate cancer
por: Miao, Chenkui, et al.
Publicado: (2022)